• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > General > April 15, 2011

      FDA Okays First Dengue Fever Test

      Posted Atmedpagetoday.com

      The FDA has cleared the first test to diagnose patients with signs and symptoms of dengue fever.

      The test, known as the DENV Detect IgM Capture ELISA, looks for dengue virus antibodies in blood samples of patients who are symptomatic for the fever.

      There are no tests currently cleared or approved by the FDA for direct detection of dengue virus.

      The new test's clearance was made possible through an alternate marketing path known as the de novo pathway, which allows for marketing of new devices that are low to moderate risk in use and that may not require premarket approval, an FDA statement said.

      The test should not be used on patients who are asymptomatic, the statement said.

      The agency warned that test results can be complicated by the IgM antibody response to dengue virus, which doesn't occur until three to five days after the fever's onset, meaning that the test may show a negative result despite infection.

      The test may also react to related viruses -- such as that responsible for West Nile disease -- but in U.S. testing results, patients that showed signs of dengue should be considered to show presumptive evidence of dengue, according to the agency.

      The test is made by Inbios, of Seattle.


      April 15, 2011



      Share this Article!

    Back to top^